Ironwood Pharmaceuticals, Inc. Reported A Surprise Loss, And Analysts Have Updated Their Forecasts [Yahoo! Finance]
Ironwood Pharmaceuticals, Inc. - Class A (IRWD)
Last ironwood pharmaceuticals, inc. - class a earnings: 2/13 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
investor.ironwoodpharma.com
Company Research
Source: Yahoo! Finance
Revenues missed expectations, with revenue of US$94m falling 12% short of forecasts. Earnings correspondingly dipped, with Ironwood Pharmaceuticals reporting a statutory loss of US$0.01 per share, where the analysts were expecting a profit. Following the result, the analysts have updated their earnings model, and it would be good to know whether they think there's been a strong change in the company's prospects, or if it's business as usual. We've gathered the most recent statutory forecasts to see whether the analysts have changed their earnings models, following these results. View our latest analysis for Ironwood Pharmaceuticals Following the recent earnings report, the consensus from six analysts covering Ironwood Pharmaceuticals is for revenues of US$392.2m in 2024. This implies a perceptible 2.1% decline in revenue compared to the last 12 months. Statutory earnings per share are predicted to bounce 767% to US$0.50. In the lead-up to this report, the analysts had been modelli
Show less
Read more
Impact Snapshot
Event Time:
IRWD
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
IRWD alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
IRWD alerts
High impacting Ironwood Pharmaceuticals, Inc. - Class A news events
Weekly update
A roundup of the hottest topics
IRWD
News
- Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) was upgraded by analysts at Leerink Partnrs to a "hold" rating.MarketBeat
- Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) is now covered by analysts at Leerink Partners. They set a "market perform" rating and a $5.00 price target on the stock.MarketBeat
- Ironwood Pharmaceuticals to Participate in the 2024 Wells Fargo Healthcare ConferenceBusiness Wire
- Analysts Have Just Cut Their Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Revenue Estimates By 13% [Yahoo! Finance]Yahoo! Finance
- Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) had its price target lowered by analysts at Wells Fargo & Company from $14.00 to $12.00. They now have an "overweight" rating on the stock.MarketBeat
IRWD
Earnings
- 8/8/24 - Miss
IRWD
Sec Filings
- 9/18/24 - Form 4
- 8/14/24 - Form 4
- 8/14/24 - Form 4
- IRWD's page on the SEC website